Roxanne Wadia, MD
Assistant Professor of PathologyAbout
Research
Publications
2024
Adaption and National Validation of a Tool for Predicting Mortality from Other Causes Among Men with Nonmetastatic Prostate Cancer
Justice A, Tate J, Howland F, Gaziano J, Kelley M, McMahon B, Haiman C, Wadia R, Madduri R, Danciu I, Leppert J, Leapman M, Thurtle D, Gnanapragasam V. Adaption and National Validation of a Tool for Predicting Mortality from Other Causes Among Men with Nonmetastatic Prostate Cancer. European Urology Oncology 2024, 7: 923-932. PMID: 38171965, DOI: 10.1016/j.euo.2023.11.023.Peer-Reviewed Original ResearchVeterans Health AdministrationCharlson Comorbidity IndexNon-prostate cancer mortalityProstate cancer mortalityNonmetastatic prostate cancerComorbidity indexCancer mortalityProvider estimationProstate cancerHealth AdministrationUS Veterans Health AdministrationElectronic health record-based toolsYear of diagnosisRisk of deathObservational cohortMedian ageNonmetastatic cancerPredicting MortalityC-statisticHispanic ethnicityTreatment groupsMortalityCancerNational validationAge
2023
TP53 Mutation-driven Stratified Mucin-producing Carcinoma Coexisting With Squamous Cell Carcinoma of the Vulva: A Case Study
Wadia R, McHenry A, Abi-Raad R, Hui P. TP53 Mutation-driven Stratified Mucin-producing Carcinoma Coexisting With Squamous Cell Carcinoma of the Vulva: A Case Study. International Journal Of Gynecological Pathology 2023, 42: 555-560. PMID: 37255422, DOI: 10.1097/pgp.0000000000000961.Peer-Reviewed Original ResearchConceptsSquamous cell carcinomaInvasive squamous cell carcinomaVulvar intraepithelial neoplasiaCell carcinomaIntraepithelial neoplasiaLichen sclerosusAssociated with high-risk human papillomavirus infectionHigh-risk human papillomavirus infectionDifferentiated vulvar intraepithelial neoplasiaPresence of lymphovascular invasionInguinal lymph node metastasisHuman papillomavirus infectionVulvar lichen sclerosusMucin-producing carcinomaLymph node metastasisIntraepithelial lesionsLymphovascular invasionTP53 mutationsNode metastasisPapillomavirus infectionNeoplastic componentsCarcinomaUnique caseTP53Sclerosus
2020
Predicting prostate cancer death among 98,994 veterans: Differences by race/ethnicity.
Janet T, Danciu I, Justice A, Leapman M, McMahon B, Wadia R. Predicting prostate cancer death among 98,994 veterans: Differences by race/ethnicity. Journal Of Clinical Oncology 2020, 38: e17609-e17609. DOI: 10.1200/jco.2020.38.15_suppl.e17609.Peer-Reviewed Original ResearchProstate cancer deathNon-Hispanic blacksNon-Hispanic whitesVeterans Affairs Healthcare SystemRace/ethnicityHazard ratioGleason scoreCancer deathProstate cancerU.S. Veterans Affairs healthcare systemProstate cancer disease progressionDistant metastatic diseaseProstate cancer mortalityCancer disease progressionLocalized diseasePSA levelsMedian ageMetastatic diseaseLymph nodesPrognostic indexCancer mortalityTumor stageDisease progressionCox modelAge strata
2019
Short-term outcomes for lung cancer resection surgery in HIV infection.
Sigel KM, Stone K, Wisnivesky JP, Park LS, Kong CY, Silverberg MJ, Brown S, Goetz M, Rodriguez-Barradas MC, Gibert C, Shebl F, Bedimo R, Wadia R, King J, Crothers K. Short-term outcomes for lung cancer resection surgery in HIV infection. AIDS 2019, 33: 1353-1360. PMID: 30889013, PMCID: PMC6565364, DOI: 10.1097/qad.0000000000002200.Peer-Reviewed Original ResearchConceptsVeterans Affairs Surgical Quality Improvement ProgramShort-term surgical complicationsVeterans Aging Cohort StudyEarly-stage lung cancerShort-term outcomesHIV statusLung cancerSurgical complicationsSurgical resectionLung cancer resection surgerySurgical Quality Improvement ProgramVeterans Affairs Corporate Data WarehouseCurative treatment regimensSetting of HIVLung cancer surgeryFrequency of complicationsAging Cohort StudyLung cancer patientsSurgical lung resectionCancer resection surgeryQuality Improvement ProgramCorporate Data WarehousePostoperative mortalityUninfected veteransPostoperative complications
2018
Impact of HIV on Clinical Presentation and Outcomes of Individuals with Multiple Myeloma
Giri S, Wong E, Rose M, Wadia R, Park L, Justice A, Neparidze N. Impact of HIV on Clinical Presentation and Outcomes of Individuals with Multiple Myeloma. Blood 2018, 132: 3162. DOI: 10.1182/blood-2018-99-115633.Peer-Reviewed Original ResearchVeterans Aging Cohort StudyMultiple myelomaEM diseaseUninfected patientsClinical characteristicsLytic lesionsOutcome of MMRisk of MMImpact of HAARTRole of HAARTStage 3 diseaseSymptomatic multiple myelomaTime of diagnosisAggressive clinical courseAging Cohort StudyClinical outcome dataCourse of diseasePlasma cell disordersDurie-Salmon stageVeterans Health AdministrationImpact of HIVSignificant differencesStage 1High rateStage 2Comparison of Natural Language Processing and Manual Coding for the Identification of Cross-Sectional Imaging Reports Suspicious for Lung Cancer
Wadia R, Akgun K, Brandt C, Fenton BT, Levin W, Marple AH, Garla V, Rose MG, Taddei T, Taylor C. Comparison of Natural Language Processing and Manual Coding for the Identification of Cross-Sectional Imaging Reports Suspicious for Lung Cancer. JCO Clinical Cancer Informatics 2018, 2: 1-7. PMID: 30652545, PMCID: PMC6873962, DOI: 10.1200/cci.17.00069.Peer-Reviewed Original Research
2014
Effect of pre-existing mental health comorbidities (MHC) on stage and timeliness of care of solid tumors in Veterans Affairs Connecticut Healthcare System (VACHS).
Wadia R, Yao X, Deng Y, Li J, Maron S, Connery D, Gunduz-Bruce H, Rose M. Effect of pre-existing mental health comorbidities (MHC) on stage and timeliness of care of solid tumors in Veterans Affairs Connecticut Healthcare System (VACHS). Journal Of Clinical Oncology 2014, 32: 6542-6542. DOI: 10.1200/jco.2014.32.15_suppl.6542.Peer-Reviewed Original Research
2010
The prevention of chemotherapy induced peripheral neuropathy by concurrent treatment with drugs used for bipolar disease: a retrospective chart analysis in human cancer patients
Wadia R, Stolar M, Grens C, Ehrlich B, Chao H. The prevention of chemotherapy induced peripheral neuropathy by concurrent treatment with drugs used for bipolar disease: a retrospective chart analysis in human cancer patients. Oncotarget 2010, 5: 2-2. DOI: 10.18632/oncotarget.23441.Peer-Reviewed Original ResearchPeripheral neuropathyNeuronal calcium sensor-1Valproic acidSide effectsBipolar diseaseRetrospective chart review studyDose-limiting side effectChemotherapeutic drugsAltered calcium signalingDevelopment of CIPNPrevention of chemotherapyInitiation of chemotherapyMain dose-limiting side effectChart review studyRetrospective chart analysisVA electronic health recordMajor adverse effectsNumber of patientsDuration of survivalCalcium signalingHuman cancer patientsAberrant calcium signalingQuality of lifeElectronic health recordsApplication of drugs
2008
506 L-Arginine Availability Is Essential for Colonic Epithelial Restitution
Singh K, Chaturvedi R, Wadia R, Asim M, Lewis N, Barry D, Wilson K. 506 L-Arginine Availability Is Essential for Colonic Epithelial Restitution. Gastroenterology 2008, 134: a-70. DOI: 10.1016/s0016-5085(08)60330-3.Peer-Reviewed Original ResearchS1757 ApoE-Mimetic Peptide COG112 Ameliorates Dextran Sulfate Sodium Colitis
Singh K, Chaturvedi R, Barry D, Asim M, Wadia R, Lewis N, Washington M, Vitek M, Wilson K. S1757 ApoE-Mimetic Peptide COG112 Ameliorates Dextran Sulfate Sodium Colitis. Gastroenterology 2008, 134: a-264. DOI: 10.1016/s0016-5085(08)61227-5.Peer-Reviewed Original Research
Clinical Care
Overview
Roxanne Wadia, MD, is a pathologist who specializes in anatomic pathology and cytopathology. She examines tissue and cell samples under a microscope to help diagnose a variety of conditions, including cancers and inflammatory diseases. Dr. Wadia’s work plays a crucial role in guiding treatment decisions by providing accurate and timely diagnoses based on laboratory analysis.
Dr. Wadia received her medical training at Vanderbilt University School of Medicine. She is a clinical fellow at Yale School of Medicine.
Clinical Specialties
Pathology; Anatomic Pathology
Board Certifications
Cytopathology
- Certification Organization
- AB of Pathology
- Original Certification Date
- 2024
Anatomic Pathology
- Certification Organization
- AB of Pathology
- Original Certification Date
- 2023